| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |